1801-1820 of 2146 < first | | | last >
  • Translating Lean from Automotive to Pharma

    Most Lean Manufacturing training uses terminology from discrete manufacturing. The University of Michigan (Ann Arbor) offers courses geared specifically to pharmaceutical manufacturing professionals. Their students are already making a difference at Pfizer, Eli Lilly and other companies.

    Paul Thomas, Managing Editor
  • Operational Excellence: Straight Talk from BMS’ Wellemeyer

    How does a pharmaceutical manufacturing plant marked for closing transform itself into a corporate model (and home to Pharmaceutical Manufacturing’s 2005 Team of the Year)? Lean, 5-S and Factory Physics were all important, but people made the real difference. Listen in as John Wellemeyer, director of Bristol-Myers Squibb’s Indiana Technical Operations, shares best practices.

  • Tuning in to New Solvents

    Tunable solvents, including supercritical fluids and ionic liquids, may not be in your stockroom — yet — but they offer significant environmental and manufacturing benefits.

    Charles A. Eckert, Charles L. Liotta, Christopher L. Kitchens and Jason P. Hallett, Georgia Institute of Technology
  • Speak Up! 10 Ways to Propel Your Career from the Podium

    As Seinfeld put it, public speaking scares more people than death itself. Is it worth the sweaty palms and nervousness? Yes, says our career expert JoAnn Hines. In fact, it may be the secret to landing the ideal job.

    JoAnn R. Hines, PharmaManufacturing’s Career Expert
  • Redefining the Workforce

    As competitive pressures increase, drug makers are becoming increasingly concerned about their “other” pipeline: the human one. Is today’s workforce up to the challenges now gripping the industry?

  • Don’t Dread PAT Pre-Op Reviews

    Look at FDA's PAT pre-op reviews as opportunities, suggests PAT expert David Radspinner. Focus on risk, and get FDA involved early.

  • First Things First: Understand Raw Material Quality

    Understanding the impact of raw material variability is critical to ensuring final product quality and to successfully initiating a PAT program.

    Paul Entrop, Product Team Director, Analyzers, Thermo Electron Corp.
  • Therapeutic Dose: Playing the Villain

    “The Constant Gardener” won’t help the wilting image of our industry, but it may open dialogue on global standards for clinical trials.

  • Handling Downsizings Right

    Downsizing offers a quick fix, but has long-term costs—and can even damage the bottom line. Whether you’re on the giving or receiving end, the right approach is critical.

  • Symbol’s Last Chance

    Two managements have struck out. The next may be the last chance for one of track & trace’s major players, says The WCCN Letter’s Tom Polizzi.

    Thomas A. Polizzi, WCCN Publishing
  • Overcome the Fear of Shear

    The mixing of biological products is delicate business, but concerns about shear sensitivity can be overblown. Rational process development, rules of thumb and tools like CFD can lead to fearless mixing.

    Thomas A. Post, Ph.D., Consultant, Post Mixing Optimization and Solutions
  • Sterilizing Filters: Right Flow, Right Size Critical

    Filtration can be the quickest, most cost-effective means to achieve sterilization for large volumes of simple buffers or aqueous solutions. However, finding the right flow rate and filter sizing is essential to meeting FDA’s aseptic guidelines.

  • Realizing ERP’s Untapped Potential

    Pharma ERP has been an underachiever for years; savvy drug makers are turning that picture around by connecting ERPs more closely to the plant floor.

    Doug Bartholomew, Contributing Editor
1801-1820 of 2146 < first | | | last >